Re-irradiation is now a real option – but how do we take it forward? by Muirhead, R, Jones, B

Incidence of symptomatic brain metastasis following radical radiotherapy for non-small cell lung cancer: is there a role for prophylactic cranial irradiation? by Khan, E, Ismail, S, Muirhead, R

A tumor control probability model for anal squamous cell carcinoma by Muirhead, R, Partridge, M, Hawkins, M

Clinical commissioning of online seed matching protocol for prostate radiotherapy. by Duffton, A, McNee, S, Muirhead, R, Alhasso, A

Use of Maximum Intensity Projections (MIPs) for target outlining in 4DCT radiotherapy planning. by Muirhead, R, McNee, S, Featherstone, C, Moore, K, Muscat, S

The potential clinical benefit of respiratory gated radiotherapy (RGRT) in non-small cell lung cancer (NSCLC). by Muirhead, R, Featherstone, C, Duffton, A, Moore, K, McNee, S

Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT) by Durrant, L, Robinson, M, Hawkins, M, den Heuvel, F, Muirhead, R

Diffusion-weighted magnetic resonance imaging as an early predictive marker of chemoradiotherapy response in squamous cell carcinoma of the anus: an individual patient data meta-an... by Hanekamp, BA, Virdee, P, Goh, V, Jones, M, Guren, MG, Muirhead, R

WE-AB-202-10: Modelling individual tumor-specific control probability for hypoxia in rectal cancer. by Warren, S, Warren, D, Wilson, J, Muirhead, R, Hawkins, M, Maughan, T, Partridge, M

Use of megavoltage cine-images for studying intra-thoracic motion during radiotherapy for locally advanced lung cancer. by Muirhead, R, van der Weide, L, de Koste, v, Cover, K, Senan, S

Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool. by van Dam, I, de Koste, v, Hanna, G, Muirhead, R, Slotman, B, Senan, S

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer by Robinson, M, Sabbagh, A, Muirhead, R, Durrant, L, Van den Heuvel, F, Hawkins, M

Association of neutrophil-to-lymphocyte ratio with survival outcomes in metastatic colorectal cancer patients treated with selective internal radiation therapy by Shiao, J, Winter, H, Greenhalgh, T, Virdee, P, Little, M, Boardman, P, Muirhead, R, Sharma, R

Personalized dose escalation in anal cancer by Robinson, M, Christophides, D, Cooper, R, Murray, P, Lilley, J, Muirhead, R, Sebag-Montefiore, D, Hawkins, M

Early stage anal margin cancer: towards evidence‐based management by Renehan, A, Muirhead, R, Berkman, L, McParland, L, Sebag-Montefiore, D, Plato Trial Management Group, Hawkins, M

Changes in pelvic active bone marrow seen on FDG-PET in patients receiving concurrent chemoradiation for anal cancer by Robinson, M, Virdee, P, Strauss, V, Cooke, R, Ng, S, Van Den Heuvel, F, Jacobs, C, Muirhead, R, Hawkins, M

Is there a role for a biological boost in squamous cell anal cancer? by Sabbagh, A, Jacobs, C, Cooke, R, Chu, K, Ng, S, Strauss, V, Virdee, P, Hawkins, M, Aznar, M, Muirhead, R

Is there a role for an FDG derived biological boost in squamous cell anal cancer? by Sabbagh, A, Jacobs, C, Cooke, R, Chu, K, Ng, S, Strauss, V, Virdee, P, Hawkins, M, Aznar, M, Muirhead, R

Is there a role for an 18F-fluorodeoxyglucose-derived biological boost in squamous cell anal cancer? by Sabbagh, A, Jacobs, C, Cooke, R, Chu, K, Ng, S, Strauss, V, Virdee, P, Hawkins, M, Aznar, M, Muirhead, R

Treatment planning of dose escalation for anal cancer in the PLATO trial by Abbott, N, Christophides, D, Robinson, M, Copeland, J, Adams, R, Harrison, M, Hawkins, M, Muirhead, R, Sebag-Montefiore, D